3.
(A) SDS-PAGE of native 5B1, DTPA-5B1, DTPA-PODS-5B1, and DTPA-PODSAJICAP-5B1; (B) autoradiography gel of [177Lu]Lu-DTPA-5B1, [177Lu]Lu-DTPA-PODS-5B1, and [177Lu]Lu-DTPA-PODSAJICAP-5B1. (C) 5-day serum stability curves of [177Lu]Lu-DTPA-5B1 (left), [177Lu]Lu-DTPA-PODS-5B1 (center), and [177Lu]Lu-DTPA-PODSAJICAP-5B1 (right); (D) bead-based immunoreactivity assays of [177Lu]Lu-DTPA-5B1 (left), [177Lu]Lu-DTPA-PODS-5B1 (center), and [177Lu]Lu-DTPA-PODSAJICAP-5B1 (right).
